Could beta blockers be doing more harm than good in some HF patients?
They have been a standard of care for years, but a new study by researchers at Johns Hopkins University Medical School suggests that beta blockers may be doing more harm than good for HF patients with the non-systolic form of the disease. It's a small study, and the findings are controversial, but investigators believe practitioners should at least give the evidence some thought when caring for this group of patients.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003971:Diastole / Q000187:drug effects / Q000502:physiology; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology; D013997:Time Factors
D000319:Adrenergic beta-Antagonists